Before HDF treatment, patients with diabetes exhibited significantly lower levels of NETosis markers than those without diabetes, including MPO (P = 0.03, n = 9), H3 (P = 0.02, n = 9), and NE (P = 0.03, n = 9). This evidence concerns the gene MPO and diabetes mellitus.